Merck agrees to pay$650M+ to settle suits

Merck has agreed to pay more than $650 million to settle two whistleblower suits, the U.S. Justice Department has announced. One of the suits claimed that the pharma paid providers to use its products, disguising kickbacks as compensation for training, consulting and market research. The other suit claimed that Merck gave hospitals volume discounts on Zocor, Vioxx and Pepcid while failing to offer Medicaid the same discounts. (Nevada, for example, concluded that Merck was charging hospitals less than 8 percent of its reported price on Zocor, while failing to give the state's Medicaid program the same price.) Former Merck sales manager H. Dean Steinke will get about $68.2 million for his role in the suits, while the other whistleblower, New Orleans physician William LaCorte, will receive $24.1 million.

To learn more about the suit:
- read this Modern Healthcare article (reg. req.)

Related Articles:
Providers settle whistle-blower suits. Report
Merck posts $1.6 billion loss. Report
Merck settling Vioxx claims for $4.85B. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.